The 200 DMA is used as a key indicator by traders for determining the overall trend in a particular stock.

Nuvama has reiterated its ‘Buy’ rating on Dr Lal PathLabs and raised the target price to Rs 2,140 from Rs 1,900, implying a potential upside of 21% from the current market price of Rs 1,756.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources

CXMT Corp’s Shanghai debut is anticipated to be historic after a near-record IPO. The company is poised to become China’s largest listed firm on its first trading day. This significant offering taps into global demand for memory chips and AI development. CXMT is China’s best hope for reducing foreign supplier dependence in critical chip areas….

CME Group will introduce single-stock futures for over fifty major US companies. These contracts offer leveraged exposure without the complexity of options trading. The exchange aims to attract new traders and manage risk for institutions. This new financial product is designed for both retail and institutional investors. It aims to capitalize on current market trends…

Global markets saw oil prices fall and stocks rise as US and Iran paused retaliatory strikes. The dollar weakened against peers while Treasuries gained as inflation concerns receded. Traders now await Federal Reserve interest rate decisions and tech company earnings reports. Central banks globally will emphasize vigilance over higher energy prices impacting inflation. Singapore tightened…

India’s primary market momentum continues with over two dozen issuers planning IPOs. These companies aim to collectively raise approximately ₹35,000 crore in the upcoming month. New-age companies like Zepto and PhonePe are expected to lead this significant market activity. Investor appetite is returning as markets stabilize, following a subdued first half. This robust pipeline signals…

Sterling & Wilson plans a ₹1,500 crore IPO for its generator unit. Proceeds will fund the company’s significant global and domestic expansion plans. The generator business has seen strong momentum, driven by data centre growth. Its order book nearly doubled in FY26, reaching ₹2,900 crore. This move aims to strengthen its market position and meet…

The Nifty 50 has declined and is now near oversold levels. Analysts suggest a potential pullback towards 24,000 if support at 23,600 is maintained. Traders are advised to consider specific option strategies for the upcoming weekly expiry. Several top stock picks are recommended with defined targets and stop losses. These include Azad Engineering, Laurus Labs,…

Indian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy’s and Cipla saw significant drops in their net profits and operating margins. However, their domestic businesses continued to perform well, offering a positive outlook. Obesity therapies and specialty product launches are expected to drive future growth for these companies….